{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:00:23Z","timestamp":1770346823995,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s12264-010-0604-1","type":"journal-article","created":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T09:39:02Z","timestamp":1265103542000},"page":"85-89","source":"Crossref","is-referenced-by-count":5,"title":["Research advancement in immunopathogenesis of myasthenia gravis","\u65e0\u529b\u7684\u514d\u75ab\u53d1\u75c5\u673a\u5236\u7814\u7a76\u8fdb\u5c55"],"prefix":"10.1007","volume":"26","author":[{"given":"Sha","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,3]]},"reference":[{"key":"604_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0404.2006.00608.x","volume":"S183","author":"G.O. Skeie","year":"2006","unstructured":"Skeie GO, Aarli JA, Gilhus NE. Titin and ryanodine receptor antibodies in myasthenia gravis. Acta Neurol Scand 2006, S183:19\u201323.","journal-title":"Acta Neurol Scand"},{"issue":"1\u20132","key":"604_CR2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2009.01.001","volume":"208","author":"T. Maruta","year":"2009","unstructured":"Maruta T, Yoshikawa H, Fukasawa S, Umeshita S, Inaoka Y, Edahiro S, et al. Autoantibody to dihydropyridine receptor in myasthenia gravis. J Neuroimmunol 2009, 208(1\u20132): 125\u2013129.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"604_CR3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/eji.200636449","volume":"37","author":"B. Tackenberg","year":"2007","unstructured":"Tackenberg B, Kruth J, Bartholomaeus JE, Schlegel K, Oertel WH, Willcox N, et al. Clonal expansions of CD4+ B helper T cells in autoimmune myasthenia gravis. Eur J Immunol 2007, 37(3): 849\u2013863.","journal-title":"Eur J Immunol"},{"issue":"44","key":"604_CR4","doi-asserted-by":"crossref","first-page":"17459","DOI":"10.1073\/pnas.0708577104","volume":"104","author":"H. Ben-David","year":"2007","unstructured":"Ben-David H, Sharabi A, Dayan M, Sela M, Mozes E. The role of CD8+CD28+ regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand. Proc Natl Acad Sci U S A 2007, 104(44): 17459\u201317464.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"604_CR5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jcp.20973","volume":"211","author":"Y.J. Bi","year":"2007","unstructured":"Bi YJ, Liu GW, Yang RF. Th17 cell induction and immune regulatory effects. J Cell Physiol 2007, 211: 273\u2013278.","journal-title":"J Cell Physiol"},{"key":"604_CR6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2332\/allergolint.R-07-160","volume":"57","author":"K. Oboki","year":"2008","unstructured":"Oboki K, Ohno T, Saito H, Nakae S. Th17 and allergy. Allergol Int 2008, 57: 121\u2013134.","journal-title":"Allergol Int"},{"key":"604_CR7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1902\/jop.2007.060392","volume":"78","author":"J.M. Kramer","year":"2007","unstructured":"Kramer JM, Gaffen SL. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol 2007, 78: 1083\u20131093.","journal-title":"J Periodontol"},{"key":"604_CR8","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.4049\/jimmunol.175.12.7898","volume":"175","author":"R. Liu","year":"2005","unstructured":"Liu R, La Cava A, Bai XF, Jee Y, Price M, Campagnolo DI, et al. Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia. J Immunol 2005, 175: 7898\u20137904.","journal-title":"J Immunol"},{"issue":"45","key":"604_CR9","first-page":"3189","volume":"88","author":"X.T. He","year":"2008","unstructured":"He XT, Liu WB, Feng HY, Zhang Y, Huang X, Meng R, et al. The role of CD4+ CD25+ T cells in the mechanism of myasthenia gravis in children and adults. Chin Med J 2008, 88(45):3189\u20133191.","journal-title":"Chin Med J"},{"key":"604_CR10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/eji.200838729","volume":"39","author":"Q.F. Kong","year":"2009","unstructured":"Kong QF, Sun B, Wang GY, Zhai DX, Mu LL, Wang DD, et al. BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO. Eur J Immunol 2009, 39: 800\u2013809.","journal-title":"Eur J Immunol"},{"issue":"1","key":"604_CR11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pharmthera.2006.03.005","volume":"112","author":"M.C. Dalakas","year":"2006","unstructured":"Dalakas MC. B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target. Pharmacol Ther 2006, 112(1): 57\u201370.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"604_CR12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.mehy.2006.06.057","volume":"68","author":"P. Sassano","year":"2007","unstructured":"Sassano P, Paparo F, Ramieri V, Colangeli W, Verdino G. Interleukine-6 (IL-6) may be a link between myasthenia gravis and myoepithelioma of the parotid gland. Med Hypotheses 2007, 68(2): 314\u2013317.","journal-title":"Med Hypotheses"},{"issue":"3","key":"604_CR13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaut.2005.01.013","volume":"24","author":"E. T\u00fcz\u00fcn","year":"2005","unstructured":"T\u00fcz\u00fcn E, Meriggioli MN, Rowin J, Yang H, Christadoss P. Myasthenia gravis patients with low plasma IL-6 and IFN-\u03b3 benefit from etanercept treatment. J Autoimmun 2005, 24(3): 261\u2013268.","journal-title":"J Autoimmun"},{"issue":"2","key":"604_CR14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cellimm.2006.08.005","volume":"241","author":"B.G. Xiao","year":"2006","unstructured":"Xiao BG, Duan RS, Zhu WH, Lu CZ. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis. Cell Immunol 2006, 241(2): 95\u2013101.","journal-title":"Cell Immunol"},{"issue":"11","key":"604_CR15","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1080\/00207450601125840","volume":"117","author":"Z. Yapici","year":"2007","unstructured":"Yapici Z, T\u00fcz\u00fcn E, Altunayo\u00f0lu V, Erdo\u00f0an A, Eraksoy M. High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis. Int J Neurosci 2007, 117(11): 1505\u20131512.","journal-title":"Int J Neurosci"},{"issue":"1","key":"604_CR16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10875-005-0357-4","volume":"25","author":"R.S. Duan","year":"2005","unstructured":"Duan RS, Link H, Xiao BG. Long-term effects of IFN-gamma, IL-10, and TGF-\u03b2-modulated dendritic cells on immune response in Lewis rats. J Clin Immunol 2005, 25(1): 50\u201356.","journal-title":"J Clin Immunol"},{"issue":"1\u20132","key":"604_CR17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2009.02.009","volume":"210","author":"E.H. Alseth","year":"2009","unstructured":"Alseth EH, Nakkestad HL, Aarseth J, Gilhus NE, Skeie GO. Interleukin-10 promoter polymorphisms in myasthenia gravis. J Neuroimmunol 2009, 210(1\u20132):63\u201366.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"604_CR18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3988\/jcn.2007.3.3.133","volume":"3","author":"H.S. Kim","year":"2007","unstructured":"Kim HS, Kim DS, Lee EY, Sunwoo IN, Choi YC. CCR2-64I and CCR5Delta32 polymorphisms in Korean patients with myasthenia gravis. J Clin Neural 2007, 3(3): 133\u2013138.","journal-title":"J Clin Neural"},{"issue":"1\u20132","key":"604_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2009.01.021","volume":"209","author":"T. Feferman","year":"2009","unstructured":"Feferman T, Aricha R, Mizrachi K, Geron E, Alon R, Souroujon MC, et al. Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-\u03b3 inducible protein 10 (IP-10) and its receptor CXCR3. J Neuroimmunol 2009, 209(1\u20132): 87\u201395.","journal-title":"J Neuroimmunol"},{"issue":"7","key":"604_CR20","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/eji.200737973","volume":"38","author":"Y. Bai","year":"2008","unstructured":"Bai Y, Liu R, Huang D, La Cava A, Tang YY, Iwakura Y, et al. CCL2 recruitment of IL-6-producing CD11b+ monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity. Eur J Immunol 2008, 38(7): 1877\u20131888.","journal-title":"Eur J Immunol"},{"issue":"2","key":"604_CR21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood-2005-06-2383","volume":"108","author":"A. Meraouna","year":"2006","unstructured":"Meraouna A, Cizeron-Clairac G, Panse RL, Bismuth J, Truffault F, Tallaksen C, et al. The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood 2006, 108(2): 432\u2013440.","journal-title":"Blood"},{"issue":"5","key":"604_CR22","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1210\/en.2004-1003","volume":"146","author":"P. Nancy","year":"2005","unstructured":"Nancy P, Berrih-Aknin S. Differential estrogen receptor expression in autoimmune myasthenia gravis. Endocrinology 2005, 146(5): 2345\u20132353.","journal-title":"Endocrinology"},{"issue":"6","key":"604_CR23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.humimm.2007.02.003","volume":"68","author":"V. Yilmaz","year":"2007","unstructured":"Yilmaz V, T\u00fct\u00fcnc\u00fc Y, Baris Hasbal N, Parman Y, Serdaroglu P, Deymeer F, et al. Polymorphisms of interferon-\u03b3, interleukin-10, and interleukin-12 genes in myasthenia gravis. Hum Immunol 2007, 68(6): 544\u2013549.","journal-title":"Hum Immunol"},{"issue":"11","key":"604_CR24","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.4049\/jimmunol.178.11.7072","volume":"178","author":"W. Wang","year":"2007","unstructured":"Wang W, Milani M, Ostlie N, Okita D, Agarwal RK, Caspi R, et al. C57BL\/6 mice genetically deficient in IL-12\/IL-23 and IFN-\u03b3 are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells. J Immunol 2007, 178(11): 7072\u20137080.","journal-title":"J Immunol"},{"issue":"1\u20132","key":"604_CR25","first-page":"41","volume":"62","author":"L. Aranka","year":"2009","unstructured":"Aranka L, Peter M, Jeno K, Katalin R, Gyula T, Emoke E, et al. Genetically determined neuromuscular disorders of some Roma families living in Hungary. Ideggyogy Sz 2009, 62(1\u20132): 41\u201347.","journal-title":"Ideggyogy Sz"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-010-0604-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12264-010-0604-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-010-0604-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:51:36Z","timestamp":1559443896000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12264-010-0604-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["604"],"URL":"https:\/\/doi.org\/10.1007\/s12264-010-0604-1","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}